申请人:Klein Markus
公开号:US20130210819A1
公开(公告)日:2013-08-15
Compounds of the formula I in which R, X, L
2
and A
1
-A
6
have the meanings indicated in Claim
1
, are PI3K inhibitors and can be employed, inter alia, for the treatment of autoimmune diseases, inflammation, cardiovascular diseases, neurodegenerative diseases and tumours.
具有公式I的化合物,在其中R、X、L2和A1-A6的含义如权利要求1所示,是PI3K抑制剂,可用于治疗自身免疫疾病、炎症、心血管疾病、神经退行性疾病和肿瘤等疾病。